Cargando…

Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds

Re-epithelialization is an important part in mucosal wound healing. Surprisingly little is known about the impact of diabetes on the molecular events of mucosal healing. We examined the role of the transcription factor forkhead box O1 (Foxo1) in oral wounds of diabetic and normoglycemic mice with ke...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fanxing, Othman, Badr, Lim, Jason, Batres, Angelika, Ponugoti, Bhaskar, Zhang, Chenying, Yi, Leah, Liu, Jian, Tian, Chen, Hameedaldeen, Alhassan, Alsadun, Sarah, Tarapore, Rohinton, Graves, Dana T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274809/
https://www.ncbi.nlm.nih.gov/pubmed/25187373
http://dx.doi.org/10.2337/db14-0589
_version_ 1782350039378558976
author Xu, Fanxing
Othman, Badr
Lim, Jason
Batres, Angelika
Ponugoti, Bhaskar
Zhang, Chenying
Yi, Leah
Liu, Jian
Tian, Chen
Hameedaldeen, Alhassan
Alsadun, Sarah
Tarapore, Rohinton
Graves, Dana T.
author_facet Xu, Fanxing
Othman, Badr
Lim, Jason
Batres, Angelika
Ponugoti, Bhaskar
Zhang, Chenying
Yi, Leah
Liu, Jian
Tian, Chen
Hameedaldeen, Alhassan
Alsadun, Sarah
Tarapore, Rohinton
Graves, Dana T.
author_sort Xu, Fanxing
collection PubMed
description Re-epithelialization is an important part in mucosal wound healing. Surprisingly little is known about the impact of diabetes on the molecular events of mucosal healing. We examined the role of the transcription factor forkhead box O1 (Foxo1) in oral wounds of diabetic and normoglycemic mice with keratinocyte-specific Foxo1 deletion. Diabetic mucosal wounds had significantly delayed healing with reduced cell migration and proliferation. Foxo1 deletion rescued the negative impact of diabetes on healing but had the opposite effect in normoglycemic mice. Diabetes in vivo and in high glucose conditions in vitro enhanced expression of chemokine (C-C motif) ligand 20 (CCL20) and interleukin-36γ (IL-36γ) in a Foxo1-dependent manner. High glucose–stimulated Foxo1 binding to CCL20 and IL-36γ promoters and CCL20 and IL-36γ significantly inhibited migration of these cells in high glucose conditions. In normal healing, Foxo1 was needed for transforming growth factor-β1 (TGF-β1) expression, and in standard glucose conditions, TGF-β1 rescued the negative effect of Foxo1 silencing on migration in vitro. We propose that Foxo1 under diabetic or high glucose conditions impairs healing by promoting high levels of CCL20 and IL-36γ expression but under normal conditions, enhances it by inducing TGF-β1. This finding provides mechanistic insight into how Foxo1 mediates the impact of diabetes on mucosal wound healing.
format Online
Article
Text
id pubmed-4274809
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-42748092016-01-01 Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds Xu, Fanxing Othman, Badr Lim, Jason Batres, Angelika Ponugoti, Bhaskar Zhang, Chenying Yi, Leah Liu, Jian Tian, Chen Hameedaldeen, Alhassan Alsadun, Sarah Tarapore, Rohinton Graves, Dana T. Diabetes Complications Re-epithelialization is an important part in mucosal wound healing. Surprisingly little is known about the impact of diabetes on the molecular events of mucosal healing. We examined the role of the transcription factor forkhead box O1 (Foxo1) in oral wounds of diabetic and normoglycemic mice with keratinocyte-specific Foxo1 deletion. Diabetic mucosal wounds had significantly delayed healing with reduced cell migration and proliferation. Foxo1 deletion rescued the negative impact of diabetes on healing but had the opposite effect in normoglycemic mice. Diabetes in vivo and in high glucose conditions in vitro enhanced expression of chemokine (C-C motif) ligand 20 (CCL20) and interleukin-36γ (IL-36γ) in a Foxo1-dependent manner. High glucose–stimulated Foxo1 binding to CCL20 and IL-36γ promoters and CCL20 and IL-36γ significantly inhibited migration of these cells in high glucose conditions. In normal healing, Foxo1 was needed for transforming growth factor-β1 (TGF-β1) expression, and in standard glucose conditions, TGF-β1 rescued the negative effect of Foxo1 silencing on migration in vitro. We propose that Foxo1 under diabetic or high glucose conditions impairs healing by promoting high levels of CCL20 and IL-36γ expression but under normal conditions, enhances it by inducing TGF-β1. This finding provides mechanistic insight into how Foxo1 mediates the impact of diabetes on mucosal wound healing. American Diabetes Association 2015-01 2014-09-03 /pmc/articles/PMC4274809/ /pubmed/25187373 http://dx.doi.org/10.2337/db14-0589 Text en © 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
spellingShingle Complications
Xu, Fanxing
Othman, Badr
Lim, Jason
Batres, Angelika
Ponugoti, Bhaskar
Zhang, Chenying
Yi, Leah
Liu, Jian
Tian, Chen
Hameedaldeen, Alhassan
Alsadun, Sarah
Tarapore, Rohinton
Graves, Dana T.
Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds
title Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds
title_full Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds
title_fullStr Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds
title_full_unstemmed Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds
title_short Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds
title_sort foxo1 inhibits diabetic mucosal wound healing but enhances healing of normoglycemic wounds
topic Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274809/
https://www.ncbi.nlm.nih.gov/pubmed/25187373
http://dx.doi.org/10.2337/db14-0589
work_keys_str_mv AT xufanxing foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT othmanbadr foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT limjason foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT batresangelika foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT ponugotibhaskar foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT zhangchenying foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT yileah foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT liujian foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT tianchen foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT hameedaldeenalhassan foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT alsadunsarah foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT taraporerohinton foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds
AT gravesdanat foxo1inhibitsdiabeticmucosalwoundhealingbutenhanceshealingofnormoglycemicwounds